Drug Database
Back to search

Switzerland· 38931001

Rifinah, comprimés enrobés

A rifampicin and isoniazid product, registered in Switzerland by Sanofi-Aventis (Suisse) SA and dispensed under Swissmedic category A. The same ATC class is registered in 9 of our 19 countries.

Cat A (Swissmedic)ATC J04AM02

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedRifinah, comprimés enrobésATCJ04AM02REGISTER NO.38931001PACKS LISTED0CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about RifinahAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rifampicin and isoniazid is registered in 9 of 19 countries.

Countries holding a registration under ATC J04AM02 (rifampicin and isoniazid), each read from that country’s own register.

  • This record: Switzerland
  • 5 of them publish a price we can compare per daily dose
Search rifampicin and isoniazid products by name

Rifampicin and isoniazid · ATC J04AM02

9 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
Sanofi-Aventis (Suisse) SA
Country
Switzerland (CH)
ATC code
J04AM02
ATC class
Rifampicin and isoniazid
Swissmedic category
A
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

61 interactions on record for rifampicin and isoniazid.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check rifampicin and isoniazid against other medicinesHow interaction checks work

Rifampicin and isoniazid · interactions on record

61 records

61 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under J04AM02

Rifampicin and isoniazid, as other registers publish it.

All rifampicin and isoniazid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8554758-b12f-46d5-9051-e9c91eb12532
GET /v1/drugs/f8554758-b12f-46d5-9051-e9c91eb12532?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Synthetika"
}
API referenceMCP serverPlans

See everything about rifampicin and isoniazid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console